Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that the United States Patent and Trademark Office (USPTO) issued a Notice of Allowance for U.S. Patent Application No. 19/253,088, titled ...
SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) ("Scienture"), a holding company for existing and planned pharmaceutical operating companies focused on providing ...
Detailed price information for Scienture Holdings Inc (SCNX-Q) from The Globe and Mail including charting and trades.
Proceeds support commercialization of Arbli, the first FDA-approved ready-to-use oral suspension for hypertension; and REZENOPY, life-saving opioid overdose emergency treatment Financing also drives ...
We wanted to determine if aliskiren was better than placebo for reducing blood pressure in adult patients with raised blood pressure, and whether this drug had increased adverse effects. We also ...
Get detailed information on Aliskiren and valsartan, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated ...
Discover comprehensive details about Aliskiren and Amlodipine, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated ...
G_hyperkalemia_web Adding aliskiren to losartan in patients with nondiabetic chronic kidney disease does not result in a greater renal protection and increases their risk of hyperkalemia, a study ...
A study published in the International Journal of Molecular Sciences, as part of a special issue “Heart Failure: From Molecular Basis to Therapy”, in August 2019, shows that aliskiren, a drug approved ...
Researchers at the University of Arizona College of Medicine - Phoenix have shown for the first time in preclinical studies that Aliskiren, a drug that inhibits the enzyme that regulates blood ...
NHS England has discarded certain items as they are of “low clinical effectiveness”. NHS England has issued a new guidance scrapping seven medicines from its prescriptions list, estimating to save ...
INCLINE VILLAGE, Nev., March 4, 2019 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL", NASDAQ: PDLI) announces the U.S. commercial launch of an authorized generic of Tekturna ®, aliskiren hemifumarate 150 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results